目的 通过观察盐酸氨基葡萄糖、依托芬那酯凝胶治疗颞下颌关节紊乱病（TMD）的临床疗效，探寻治疗老年TMD的有效治疗方法。 方法 对2008年7月－2011年12月收治的 35例老年TMD患者，予口服盐酸氨基葡萄糖胶囊750 mg，2次/d，依托芬那酯凝胶5 cm局部外涂，3～4次/d，治疗时间为6周，并对治疗前、后颞下颌关节疼痛程度和活动度进行临床疗效评价。 结果 经治疗，35例患者颞下颌关节疼痛缓解，关节活动度亦明显改善；依据疗效评定标准，治愈10例，显效16例，好转7例，无效2例，总有效率达94.3%；治疗过程中，4例出现轻度胃胀、恶心等不适，2例出现局部皮肤轻度瘙痒现象，无1例中途退出或失访。 结论 盐酸氨基葡萄糖联合依托芬那酯凝胶治疗老年TMD，能缓解关节症状，改善关节活动度，副作用少，值得临床推广运用。
【摘要】 目的 探讨护理不良事件报告机制的构建与完善情况。 方法 根据护理工作不良事件发生的类别、范围，确定不良事件报告原则，报告程序，构建护理不良事件报告机制。 结果 护理不良事件申报机制形成后，院内护理不良事件发生率及重复发生率逐月下降、主动申报率上升，与构建护理不良事件报告机制前一年比较，差异有统计学意义（Plt;0.05）。 结论 护理不良事件报告机制有助于护理安全管理。【Abstract】 Objective To investigate the construction and improvement of reporting system of nursing adverse events. Methods According to the types and scales of the nursing adverse events, reporting principles and procedures were confirmed, and the reporting system of nursing adverse events was constructed. Results The rates of nursing adverse events and repetition incidence decreased gradually and the rate of initiative declaring increased significantly compared with those one year before the construction of the reporting system (Plt;0.05). Conclusion Reporting system of nursing adverse events helps to improve the management of nursing security.
目的 探讨康复护理日常生活活动（RNADL）评定在小儿脑性瘫痪（脑瘫）手术后护理的价值。 方法 选择2012年6月－10月200例脑瘫术后患儿为研究对象，随机分为观察组和对照组，每组100例，采用 RNADL对两组患儿进行功能障碍分型判断及障碍等级评定，并分别实施相应治疗方案及护理措施，并就2个月后的康复效果进行评价。 结果 与入组时比较，观察组患儿在2个月时的RNADL评分显著增高（P＜0.01），其2个月时重度障碍的患儿较对照组明显减少（P＜0.05）。 结论 RNADL评定是脑瘫患儿康复治疗的前提和基础，通过正规RNADL评定后采取合理有效的康复治疗方案能明显改善患儿的日常生活能力。
目的 通过检测浸润性乳腺癌中白细胞介素18（IL-18）和血管内皮生长因子（VEGF）的表达情况，探讨其表达相关性及与临床病理学参数的关系。 方法 应用免疫组织化学法检测IL-18和VEGF在42例浸润性乳腺癌组织和12例正常乳腺组织中的表达情况。 结果 IL-18和VEGF在42例浸润性乳腺癌中的表达阳性率均显著高于12例正常乳腺组织（P＜0.05）。且在42例浸润性乳腺癌组织中，IL-18阳性组中VEGF阳性率（87.1%）显著高于IL-18阴性组中VEGF阳性率（12.9%），差异有统计学意义（P＜0.05）。在亚组分析中，IL-18的表达只与有无腋窝淋巴结转移有相关性（P＜0.05），而VEGF的表达与有无腋窝淋巴结转移和TNM分期有相关性（P＜0.05）。 结论 在浸润性乳腺癌中，IL-18的表达上调与VEGF的表达上调显著相关，IL-18可能具有促进肿瘤新生血管形成的作用。
Transcatheter aortic valve replacement (TAVR) is an important treatment for patients with symptomatic severe aortic stenosis. The 2020 updated version of Chinese Expert Consensus on Transcatheter Aortic Valve Replacement was born in the process of Chinese exploration for TAVR. It is of epochal guiding significance for TAVR in China, which has entered a stage of rapid development from the initial stage. Moreover, it further promotes the standardized and healthy development of TAVR in China. The 2020 updated version of Chinese Expert Consensus on Transcatheter Aortic Valve Replacement, based on its 2015 version, has included aortic valve stenosis with a low risk of surgical operation as an indication, made more detailed recommendations on the operating specifications of balloon dilation and valve placement during TAVR, added the antithrombotic program after TAVR, and important opinions on the treatment of coronary atherosclerotic heart disease, renal insufficiency, and emergency TAVR. In this article, we will focus on all these updates to interpret the updated consensus in detail.
Objective To systematically review the efficacy and safety of non-ergoline dopamine agonists (pramipexole, ropinirole, and rotigotine) and α2δ ligands (pregabalin and gabapentin-enacarbil) in the treatment of restless legs syndrome (RLS). Methods The PubMed, EMbase, The Cochrane Library, CBM, WanFang Data, and CNKI databases were electronically searched for randomized controlled trials (RCTs) assessing different medications for RLS from 2000 to 2021. Two reviewers independently screened the literature, extracted data, and assessed the risk of bias of the included studies. The network meta-analysis was then performed using Stata 16.0 software and R 4.1.0 software. Results A total of 36 RCTs involving 7 666 patients were included. The results of the network meta-analysis showed that gabapentin-enacarbil decreased IRLS scores to the greatest extent among all drugs (MD=−6.42, 95%CI −8.8 to −4.16), was superior to pramipexole (MD=−3.27, 95%CI −6.54 to −0.15), and was associated with the highest CGI-I response rates (RR=1.73, 95%CI 1.52 to 2.00). In terms of tolerance and safety, patients receiving rotigotine presented an increased incidence of withdrawal due to adverse events. Ropinirole had the highest incidence of nausea. Headache was most common side effect in rotigotine, while the incidences of somnolence and dizziness were higher in gabapentin-enacarbil than other treatments. Conclusion Current evidence suggests that gabapentin-enacarbil may be the best treatment for RLS. Rotigotine is associated with the worst tolerance. For safety, nausea is most common in ropinirole, headache is most common for rotigotine, and patients receiving gabapentin-enacarbil show increased incidences of somnolence and dizziness.
【摘要】 目的 比较酸性成纤维细胞生长因子(acid fibroblast growth factor,aFGF或FGF1)在正常乳腺组织、乳腺良性肿瘤及乳腺癌中的表达差异,探讨FGF1与乳腺癌血管生成的关系。方法 应用免疫组织化学(immunohistochemistry,IHC)SP法检测FGF1在40例乳腺癌组织、12例良性乳腺肿瘤组织及12例正常乳腺组织中的表达情况；以CD34抗体标记血管内皮细胞CD34抗原行乳腺癌组织微血管密度(micro vessel density,MVD)计数。〖HTH〗结果〖HTSS〗 FGF1在40例乳腺癌中的阳性表达率（57.5%，23/40)显著高于12例乳腺良性肿瘤组织中阳性表达率(16.7%,2/12)以及正常乳腺组织阳性表达率(0,0/12),差异有统计学意义(Plt;0.05)；良性肿瘤组FGF1表达率和正常乳腺组织比较无统计学意义(Pgt;0.05)。40例乳腺癌组织MVD计数为(70.17±29.33)个/HP,在23例FGF1阳性组中MVD计数为(89.48±23.23)个/HP,显著高于17例阴性组(44.06±12.53)个/HP,差异有统计学意义(Plt;0.05)。〖HTH〗结论 〖HTSS〗FGF1可能参与乳腺癌微血管生成。
ObjectivesTo evaluate the reporting quality of individual/focus group interviews published in nursing journals included in the Chinese science citation database (CSCD).MethodsCSCD database was electronically searched to collect qualitative studies published in nursing journals included in CSCD from January 2016 to December 2018. Two researchers independently screened literatures, extracted data, and assessed the quality of included studies by COREQ guidelines, SPSS 25.0 software was then used for statistical analysis.ResultsA total of 223 qualitative researches were included. The results of COREQ evaluation showed that full report rate of 43.8% (14/32) studies were less than 50%, 78.6% (11/14) were less than 20%, and the full report rate of item 4 was even 0%. There were no significant differences between different total cites and the availability of funding in COREQ guidelines.ConclusionThe reporting quality of the qualitative researches published in the four nursing journals included in the CSCD requires further improvement. Therefore, we suggest that domestic nursing journals should introduce COREQ guidelines in contribution and strictly implement it in editorial review and peer review.
Objective To systematically review and analyze the risk factors of epilepsy in children, to explore the related etiology of epilepsy in children, and to provide evidence-based strategies for reducing the occurrence of epilepsy in children. Methods PubMed, Embase, VIP, CNKI, Web of science, Cohrane, and CBM were searched for relevant studies on risk factors for childhood epilepsy since the establishment of the database, and the study type was selected as a case-control study. After screening and quality evaluation, the literatures that met the requirements were finally selected for inclusion in the study, and the extracted target data were statistically analyzed by RevMan5.3 software. Results A total of 9 literatures were included for Meta-analysis of the risk factors of epilepsy in children. A total of 3792 cases were studied, including 1 922 cases in the control group and 1 870 cases in the case group. Meta-analysis results showed that adverse perinatal period, family history of epilepsy, febrile seizures, and central nervous system infection were closely related to the occurrence of epilepsy in children, and the OR values were OR=3.46, 95%CI (2.51, 4.79), OR=4.77, 95%CI (3.83, 5.95), OR=7.81, 95%CI ( 5.64, 10.80), OR=3.00, 95%CI (1.44, 6.26), P values were all less than 0.05. Conclusions Adverse perinatal period, family history of epilepsy, febrile seizures, and central nervous system infection are the current risk factors for childhood epilepsy.
ObjectiveTo investigate the correlation between UBE2Q1 expression and clinicopathologic features and prognosis of lung adenocarcinoma. MethodsThis study retrospectively chose the cancer tissue and para-carcinoma tissue samples of 74 patients with stage I to III lung adenocarcinoma who received radical resection in Nanjing Chest Hospital from January 2013 to December 2016. Immunohistochemistry staining was used to detect the expression level of UBE2Q1, and patients were divided into high-expression group and low-expression group according to the Immunohistochemistry staining score. The correlation of UBE2Q1 expression level and clinicopathological characteristics was analyzed by Chi-square test. Kaplan-Meier survival curve analyzed the correlation between UBE2Q1 and prognosis of lung adenocarcinoma patients. The risk factors affecting the survival of lung adenocarcinoma patients were analyzed by univariate and multivariate Cox proportional risk models. ResultsUBE2Q1 was highly expressed in lung adenocarcinoma tissues, and the expression level was correlated with tumor diameter, lymph node metastasis, and TNM stage (P<0.05), and did not correlate with patients’ gender, age, smoking history, and tumor differentiation (P>0.05). The results of the Kaplan-Meier survival analysis showed that patients with low expression of UBE2Q1 compared with those with high expression of UBE2Q1 had longer DFS and OS (both P<0.05). Cox proportional risk model showed that tumor diameter, lymph node metastasis, TNM stage, and high UBE2Q1 expression were the risk factors for DFS and OS, among which TNM stage was an independent risk factor. ConclusionUBE2Q1 was highly expressed in lung adenocarcinoma tissues and correlated with large tumor diameter, lymph node metastasis, late TNM stage and poorer prognosis in lung adenocarcinoma, and UBE2Q1 was a risk factor for lung adenocarcinoma.